Blast Club
TIME TO IGNITE OUR TRUE STORY We believe we can all find a reality that matches our core desires. Call it ‘living my true story'. We don't expect the world would take the initiative. We are doing it nonetheless. For this, we foster how to live with authenticity through art, anecdotes, product allies, and events.
Investing activity
Blast Club appears in 2 AI deals tracked by the AI Lounge deals desk, rounds totalling $26M. The rounds are mostly Series B and Seed, with a median round size of $26M. The most recent are WhiteLab Genomics (Series B, $26M, Oct 2026) and Patientdesk.ai (Seed, $2.8M, Apr 2026).
Blast Club most often invests alongside AVP, Debiopharm Innovation Fund, Omnes Capital and Yaday Health, and the companies it backs on AI Lounge are mostly in AI biotech / genomic medicine and AI.
Deals
Frequently asked questions about Blast Club
What AI companies has Blast Club invested in?
Blast Club's AI investments include WhiteLab Genomics and Patientdesk.ai. The 2 rounds on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Blast Club based?
Blast Club is based in Geneva, Geneva, Switzerland.
What stage does Blast Club invest at?
In the rounds tracked on AI Lounge, Blast Club has invested at Series B and Seed, with a median round of $26M.
Who does Blast Club co-invest with?
Blast Club's most frequent co-investors on AI Lounge are AVP (1 deal), Debiopharm Innovation Fund (1 deal), Omnes Capital (1 deal), Yaday Health (1 deal) and First Peak Ventures (1 deal).
How can founders reach Blast Club?
Founders on AI Lounge can see Blast Club's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Blast Club to their Investor Pipeline to track the conversation.